All In MedTech

FDA Clearance Tracker · P130004-S002

RESURE SEALANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 21, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 21, 2016

Approved

Time to decision

895 days

Received Feb 7, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130004-S002
Device name
RESURE SEALANT
Applicant location
Bedford, MA
Received
Feb 7, 2014
Decided
Jul 21, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P130004

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code PFZ

FDA's approval statement

As written in FDA's record.

Approval for the ReSure® Sealant Device Exposure Registry post-approval study protocol.

Source documents

Other decisions for Ocular Therapeutix, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.